Abstract
We have used a phospholipase C (PLC)-deletion mutant (plcABC) of the H37Rv strain of Mycobacterium tuberculosis (MTB), as well as a plcA-insertion mutant of Mycobacterium smegmatis, to investigate the possible involvement of PLCs in clofazimine-mediated inhibition of mycobacterial K+ transport and growth. Inactivation of the PLCs of MTB and insertion of the plcA gene into M. smegmatis resulted in a substantial reduction and increase in hydrolysis of phosphatidylcholine (PC), respectively. However, both the mutant and wild-type strains of MTB and M. smegmatis were equally sensitive to the inhibitory effects of clofazimine on K+ uptake and growth. These observations demonstrate that the PLCs of MTB are not involved in the antimicrobial activity of clofazimine. © The British Society for Antimicrobial Chemotherapy 2004; all rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Bopape, M. C., Steel, H. C., Cockeran, R., Matlola, N. M., Fourie, P. B., & Anderson, R. (2004). Antimicrobial activity of clofazimine is not dependent on mycobacterial C-type phospholipases. Journal of Antimicrobial Chemotherapy, 53(6), 971–974. https://doi.org/10.1093/jac/dkh215
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.